Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

2nd IFOM-IEO Campus Meeting on Cancer - New therapeutic anti-cancer strategies: shortening telomeres

08.05.2006


Without the enzyme that “regenerates” telomeres (the ends of DNA), stem cells lose functionality and the organism rapidly ages, while it acquires cancer resistance. The finding, which has significant implications in cancer and aging research, was presented yesterday at the 2nd IFOM-IEO Campus Meeting on Cancer (May 5th – 8th, IFOM-IEO Campus, Milan, Italy) by Marìa A. Blasco, of the Spanish National Cancer Center (CNIO) in Madrid (Spain).



Our cells’ DNA has a sort of “tail”: the telomeres. Every time our cells divide, telomeres get shorter and shorter. This progressive telomere shortening is compensated by the action of a specific enzyme, called “telomerase”, which is able to regenerate the tails; but in our cells there is not enough telomerase to keep telomeres at a constant length during our lifetime. And when telomeres get too short, cells stop replicating. Scientists have long hypothesized (and partially proved, with several experiments) that telomere shortening is correlated, on the one hand, to the general aging of the body (when many cells in a tissue stop replicating, the tissue becomes unable to regenerate itself and gets “old”) and, on the other hand, to cancer (tumour cells replicate much more than normal cells, therefore they need some mechanism to counteract natural telomere shortening).

To make the picture even more complicated, stem cells (the other big “stars” of modern biology research) might be the only cells that are able to produce the enzyme telomerase. Intuitively this makes sense, since stem cells are the “mother cells” of all cells, and they are necessary to the body to regenerate tissues and organs during lifetime. But, what is the role of telomerase in stem cells? And what could happen if the enzyme is absent? To answer these questions, Blasco and colleagues set up a series of experiments in mice. And they found that the lack of telomerase causes a severe defect in the fundamental functions of stem cells. “In particular – Blasco said – we have been looking at skin stem cells. And we observed that, in genetically modified mice that did not express telomerase, stem cells lost their functionality and became unable to regenerate the damaged epithelial tissue. On the whole, these mice aged more rapidly than normal mice. But, there was a very interesting side effect: without telomerase, mice showed a marked cancer resistance.” Further experiments on telomeres structure showed that every time the shortening process is altered, the result is either “early aging and cancer resistance” (if shortening is boosted), or “aging inhibition and more cancer occurrence” (if shortening is reduced).


“In our lab – Blasco added – we do basic research, but our results provide fundamental knowledge to those who work on the development of new therapeutic tools. In this very moment, preclinical trials are being carried out on drugs that are able to boost the action of telomerase. The potential anti-aging effect of these drugs might prove useful in the treatment of diseases such as AIDS, where tissues age rapidly. In tumours, it is necessary to implement the opposite strategy: there are drugs, now in clinical trials, that inhibit telomerase action and increase telomeres shortening.” In the light of the new finding, such therapy might prove to be effective against cancer stem cells, that today are considered the most “malignant” culprit of cancer.

Francesca Noceti | alfa
Further information:
http://www.ifom-ieo-campus.it
http://www.semm.it/meeting/cancer06/

More articles from Health and Medicine:

nachricht UIC researchers find unique organ-specific signature profiles for blood vessel cells
18.02.2020 | University of Illinois at Chicago

nachricht Remdesivir prevents MERS coronavirus disease in monkeys
14.02.2020 | NIH/National Institute of Allergy and Infectious Diseases

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Freiburg researcher investigate the origins of surface texture

Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.

Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...

Im Focus: Skyrmions like it hot: Spin structures are controllable even at high temperatures

Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices

The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...

Im Focus: Making the internet more energy efficient through systemic optimization

Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.

Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.

Im Focus: New synthesis methods enhance 3D chemical space for drug discovery

After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.

"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.

Im Focus: Quantum fluctuations sustain the record superconductor

Superconductivity approaching room temperature may be possible in hydrogen-rich compounds at much lower pressures than previously expected

Reaching room-temperature superconductivity is one of the biggest dreams in physics. Its discovery would bring a technological revolution by providing...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

70th Lindau Nobel Laureate Meeting: Around 70 Laureates set to meet with young scientists from approx. 100 countries

12.02.2020 | Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

 
Latest News

Movement of a liquid droplet generates over 5 volts of electricity

18.02.2020 | Power and Electrical Engineering

Powering the future: Smallest all-digital circuit opens doors to 5 nm next-gen semiconductor

18.02.2020 | Information Technology

Studying electrons, bridging two realms of physics: connecting solids and soft matter

18.02.2020 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>